Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 51% ± 20% | |
lung | 12 studies | 32% ± 13% | |
eye | 9 studies | 37% ± 19% | |
peripheral blood | 8 studies | 24% ± 11% | |
heart | 5 studies | 42% ± 12% | |
kidney | 5 studies | 32% ± 15% | |
intestine | 5 studies | 22% ± 8% | |
liver | 4 studies | 43% ± 17% | |
adipose | 4 studies | 49% ± 27% | |
lymph node | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 15220.52 | 21 / 21 | 100% | 36.93 | 504 / 504 |
prostate | 100% | 23247.47 | 245 / 245 | 100% | 40.80 | 502 / 502 |
thymus | 100% | 19169.56 | 653 / 653 | 100% | 43.17 | 605 / 605 |
uterus | 100% | 21146.67 | 170 / 170 | 100% | 38.58 | 459 / 459 |
esophagus | 100% | 14672.91 | 1444 / 1445 | 100% | 21.52 | 183 / 183 |
breast | 100% | 13175.15 | 459 / 459 | 100% | 36.12 | 1116 / 1118 |
adrenal gland | 100% | 14211.73 | 258 / 258 | 100% | 29.04 | 229 / 230 |
pancreas | 100% | 9049.98 | 328 / 328 | 99% | 36.54 | 177 / 178 |
lung | 100% | 15366.21 | 578 / 578 | 99% | 29.54 | 1148 / 1155 |
intestine | 100% | 16521.50 | 966 / 966 | 99% | 28.39 | 523 / 527 |
stomach | 100% | 11013.31 | 359 / 359 | 99% | 25.31 | 283 / 286 |
skin | 100% | 9041.22 | 1807 / 1809 | 99% | 32.07 | 466 / 472 |
liver | 100% | 8091.34 | 226 / 226 | 99% | 18.16 | 400 / 406 |
kidney | 100% | 12383.21 | 89 / 89 | 98% | 26.13 | 885 / 901 |
brain | 98% | 8038.89 | 2594 / 2642 | 100% | 51.42 | 705 / 705 |
ovary | 100% | 19912.57 | 180 / 180 | 97% | 21.45 | 417 / 430 |
adipose | 100% | 12174.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 62.75 | 29 / 29 |
spleen | 100% | 23378.26 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 43.46 | 1 / 1 |
blood vessel | 100% | 12749.74 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 8158.55 | 858 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 5152.69 | 789 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 6513.98 | 844 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 16.29 | 66 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0006396 | Biological process | RNA processing |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | RBM6 |
Protein name | RNA binding motif protein 6 RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3) |
Synonyms | DEF3 |
Description | FUNCTION: Specifically binds poly(G) RNA homopolymers in vitro. |
Accessions | ENST00000443081.5 ENST00000446471.1 E9PGM9 C9JSL1 F8WF63 ENST00000442092.5 [P78332-2] ENST00000438912.1 ENST00000425608.5 [P78332-3] F8WCA5 ENST00000433811.1 ENST00000454079.5 C9J250 ENST00000266022.9 [P78332-1] C9JII0 ENST00000421682.1 C9JMC8 P78332 ENST00000422955.5 [P78332-2] ENST00000434592.5 ENST00000419610.5 F8WCT0 |